The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Babich Michael L since 2013.
The trader's CIK number is 1368078.
At the time of the last reporting, Babich Michael L was the President and CEO of Insys Therapeutics, Inc.. (stock ticker symbol INSY).
Also see all insider trading activities at Insys Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | INSY | 0 | $0 | 75,000 | $4,415,760 | 126,068 | $574,108 |
| 2014 | INSY | 0 | $0 | 388,432 | $26,928,162 | 427,125 | $1,212,355 |
| 2013 | INSY | 2,250 | $38,560 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-09-22 | INSY | Option Ex | 16,068 | 1.62 | 26,030 |
| 2015-03-20 | INSY | Option Ex | 5,000 | 3.25 | 16,250 |
| 2015-03-17 | INSY | Sale | 27,400 | 58.09 | 1,591,748 |
| 2015-03-16 | INSY | Sale | 47,600 | 59.33 | 2,824,012 |
| 2015-03-17 | INSY | Option Ex | 27,400 | 7.26 | 198,924 |
| 2015-03-16 | INSY | Option Ex | 77,600 | 4.29 | 332,904 |
| 2014-12-19 | INSY | Option Ex | 2,500 | 3.25 | 8,125 |
| 2014-11-03 | INSY | Option Ex | 72,500 | 2.36 | 171,100 |
| 2014-11-04 | INSY | Option Ex | 7,500 | 2.36 | 17,700 |
| 2014-11-03 | INSY | Sale | 72,500 | 39.06 | 2,831,560 |
| 2014-11-04 | INSY | Sale | 7,500 | 37.27 | 279,502 |
| 2014-10-21 | INSY | Option Ex | 20,000 | 3.54 | 70,800 |
| 2014-10-21 | INSY | Sale | 20,000 | 40.17 | 803,400 |
| 2014-10-16 | INSY | Option Ex | 5,000 | 3.25 | 16,250 |
| 2014-10-10 | INSY | Option Ex | 10,000 | 3.25 | 32,500 |
| 2014-05-15 | INSY | Option Ex | 7,500 | 3.25 | 24,375 |
| 2014-03-18 | INSY | Option Ex | 90,000 | 3.35 | 301,950 |
| 2014-03-05 | INSY | Option Ex | 212,125 | 2.69 | 569,555 |
| 2014-03-05 | INSY | Sale | 288,432 | 79.79 | 23,013,700 |
| 2013-08-16 | INSY | Buy | 1,000 | 24.90 | 24,899 |
| 2013-06-04 | INSY | Buy | 1,250 | 10.93 | 13,661 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Babich Michael L (President and CEO of Insys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.